Peter Barrett, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 241,982 shares at $17.20 ($4.1M) on 2006-03-06, disclosed to the SEC on 2006-03-07.
Open-market sale of $4.1M ALNY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.89 | 942 | $16K | 0.4% |
| 2 | $16.89 | 1,879 | $32K | 0.8% |
| 3 | $16.89 | 2,771 | $47K | 1.1% |
| 4 | $16.89 | 14,043 | $237K | 5.8% |
| 5 | $16.89 | 56,528 | $955K | 23.2% |
| 6 | $16.89 | 102,619 |
| $1.7M |
| 42.2% |
| 7 | $17.20 | 333 | $6K | 0.1% |
| 8 | $17.20 | 664 | $11K | 0.3% |
| 9 | $17.20 | 980 | $17K | 0.4% |
| 10 | $17.20 | 4,964 | $85K | 2.1% |
| 11 | $17.20 | 19,983 | $344K | 8.4% |
| 12 | $17.20 | 36,276 | $624K | 15.2% |
| Total | $16.97 avg | 241,982 | $4.1M | 100% |
| Filing → |
| PKI | SELL | 2017-11-14 | $1.0M | — | Filing → |
| PKI | SELL | 2017-06-02 | $632K | — | Filing → |
| VTAE | BUY | 2014-10-01 | $300K | — | Filing → |